NasdaqCM - Nasdaq Real Time Price USD

Aurora Cannabis Inc. (ACB)

Compare
6.08 +0.07 (+1.16%)
At close: August 30 at 4:00 PM EDT
6.05 -0.03 (-0.49%)
After hours: August 30 at 7:52 PM EDT
Loading Chart for ACB
DELL
  • Previous Close 6.01
  • Open 6.01
  • Bid 6.06 x 400
  • Ask 6.10 x 500
  • Day's Range 5.97 - 6.11
  • 52 Week Range 2.84 - 11.50
  • Volume 637,572
  • Avg. Volume 1,431,338
  • Market Cap (intraday) 332.338M
  • Beta (5Y Monthly) 2.72
  • PE Ratio (TTM) --
  • EPS (TTM) -0.47
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 31.97

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

www.auroramj.com

1,073

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ACB

View More

Research Reports: ACB

View More

Performance Overview: ACB

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACB
27.73%
S&P/TSX Composite index
11.39%

1-Year Return

ACB
36.63%
S&P/TSX Composite index
15.06%

3-Year Return

ACB
91.53%
S&P/TSX Composite index
13.09%

5-Year Return

ACB
99.09%
S&P/TSX Composite index
42.49%

Compare To: ACB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACB

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    331.04M

  • Enterprise Value

    321.11M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.60

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    1.55

  • Enterprise Value/EBITDA

    55.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.53%

  • Return on Assets (ttm)

    -1.87%

  • Return on Equity (ttm)

    -6.13%

  • Revenue (ttm)

    278.98M

  • Net Income Avi to Common (ttm)

    -30.32M

  • Diluted EPS (ttm)

    -0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    115.49M

  • Total Debt/Equity (mrq)

    16.95%

  • Levered Free Cash Flow (ttm)

    -106.21M

Research Analysis: ACB

View More

Company Insights: ACB

People Also Watch